Literature DB >> 25523627

Diagnostic performance of different pleural fluid biomarkers in tuberculous pleurisy.

J Klimiuk1, R Krenke, A Safianowska, P Korczynski, R Chazan.   

Abstract

Due to the paucibacillary nature of tuberculous pleural effusion the diagnosis of pleural tuberculosis is challenging. This prospective study was undertaken to evaluate the diagnostic performance of ten different pleural fluid biomarkers in the differentiation between tuberculous and non-tuberculous pleural effusions. Two hundred and three patients with pleural effusion (117 men and 86 women, median age 65 years) were enrolled. Routine diagnostic work-up, including thoracentesis and pleural fluid analysis, was performed to determine the cause of pleural effusion. The following biomarkers were measured in pleural fluid: adenosine deaminase (ADA), interferon gamma (IFN-γ), interleukin 2 soluble receptor (IL-2sRα), sub-unit p40 of interleukin 12b (IL-12p40), interleukin 18 (IL-18), interleukin 23 (IL-23), IFN-γ induced protein 10 kDa (IP-10), Fas-ligand, human macrophage-derived chemokine (MDC) and tumor necrosis factor alfa (TNF-α). There were 44 (21.7%) patients with tuberculous pleural effusion, 88 (43.3%) patients with malignant pleural effusion, 35 (17.2%) with parapneumonic effusion/pleural empyema, 30 (14.8%) with pleural transudates, and 6 (3%) with miscellaneous underlying diseases. Pleural fluid IFN-γ was found the most accurate marker differentiating tuberculous from non-tuberculous pleural effusion, with sensitivity, specificity, PPV, NPV, and AUC 97%, 98%, 95.5%, 99.4%, and 0.99, respectively. Two other biomarkers (IP-10 and Fas ligand) also showed very high diagnostic accuracy with AUC≥0.95. AUC for ADA was 0.92. We conclude that IFN-γ, IP-10, and Fas-ligand in pleural fluid are highly accurate biomarkers differentiating tuberculous from non-tuberculous pleural effusion.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25523627     DOI: 10.1007/5584_2014_105

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  Significance of congestive heart failure as a cause of pleural effusion: Pilot data from a large multidisciplinary teaching hospital.

Authors:  Piotr Korczyński; Katarzyna Górska; Damian Konopka; Dżamila Al-Haj; Krzysztof J Filipiak; Rafał Krenke
Journal:  Cardiol J       Date:  2018-11-08       Impact factor: 2.737

Review 2.  Advances in the diagnosis of tuberculous pleuritis.

Authors:  José M Porcel
Journal:  Ann Transl Med       Date:  2016-08

Review 3.  Diagnostic value of interleukins for tuberculous pleural effusion: a systematic review and meta-analysis.

Authors:  Ni Zeng; Chun Wan; Jiangyu Qin; Yanqiu Wu; Ting Yang; Yongchun Shen; Fuqiang Wen; Lei Chen
Journal:  BMC Pulm Med       Date:  2017-12-08       Impact factor: 3.317

4.  Formation of Foamy Macrophages by Tuberculous Pleural Effusions Is Triggered by the Interleukin-10/Signal Transducer and Activator of Transcription 3 Axis through ACAT Upregulation.

Authors:  Melanie Genoula; José Luis Marín Franco; Maeva Dupont; Denise Kviatcovsky; Ayelén Milillo; Pablo Schierloh; Eduardo Jose Moraña; Susana Poggi; Domingo Palmero; Dulce Mata-Espinosa; Erika González-Domínguez; Juan Carlos León Contreras; Paula Barrionuevo; Bárbara Rearte; Marlina Olyissa Córdoba Moreno; Adriana Fontanals; Agostina Crotta Asis; Gabriela Gago; Céline Cougoule; Olivier Neyrolles; Isabelle Maridonneau-Parini; Carmen Sánchez-Torres; Rogelio Hernández-Pando; Christel Vérollet; Geanncarlo Lugo-Villarino; María Del Carmen Sasiain; Luciana Balboa
Journal:  Front Immunol       Date:  2018-03-09       Impact factor: 7.561

5.  Identifying tuberculous pleural effusion using artificial intelligence machine learning algorithms.

Authors:  Zenghua Ren; Yudan Hu; Ling Xu
Journal:  Respir Res       Date:  2019-10-16

6.  Role of cancer ratio and other new parameters in the differential diagnosis of malignant pleural effusion.

Authors:  Zenghua Ren; Ling Xu
Journal:  Clinics (Sao Paulo)       Date:  2021-04-26       Impact factor: 2.365

Review 7.  Pleural Fluid Soluble Interleukin-2 Receptor as a Biomarker for the Diagnosis of Tuberculosis Pleural Effusion: A Systematic Review and Meta-Analysis.

Authors:  Zhi Yan; Hua Wang; Wen-Qi Zheng; Zhi-De Hu
Journal:  J Trop Med       Date:  2022-03-20

8.  A scoring model for diagnosis of tuberculous pleural effusion.

Authors:  Senquan Wu; Shaomei Li; Nianxin Fang; Weiliang Mo; Huadong Wang; Ping Zhang
Journal:  BMC Pulm Med       Date:  2022-09-02       Impact factor: 3.320

9.  Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays.

Authors:  Wenjing Xiong; Haiping Dong; Juanjuan Wang; Xiaoming Zou; Qian Wen; Wei Luo; Sudong Liu; Jianchun He; Shaoxi Cai; Li Ma
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240

10.  Fatty acid oxidation of alternatively activated macrophages prevents foam cell formation, but Mycobacterium tuberculosis counteracts this process via HIF-1α activation.

Authors:  Melanie Genoula; José Luis Marín Franco; Mariano Maio; Belén Dolotowicz; Malena Ferreyra; M Ayelén Milillo; Rémi Mascarau; Eduardo José Moraña; Domingo Palmero; Mario Matteo; Federico Fuentes; Beatriz López; Paula Barrionuevo; Olivier Neyrolles; Céline Cougoule; Geanncarlo Lugo-Villarino; Christel Vérollet; María Del Carmen Sasiain; Luciana Balboa
Journal:  PLoS Pathog       Date:  2020-10-01       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.